Neuroblastoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
Rochelle BagatellJulie R ParkSahaja AcharyaJennifer AldrinkJenna AllisonElizabeth AlvaCarola ArndtDaniel BenedettiErin BrownSteve ChoAlanna ChurchAndrew DavidoffAmi DesaiSteven DuBoisDouglas FairJoaquim FarinhasDouglas HarrisonFrederick HuangPaul IskanderSusan KreissmanMargaret MacyBrian NaFarzana PashankarPraveen PendyalaNavin PintoStephanie PolitesRaja RabahHiroyuki ShimadaLeonora SlatnickElizabeth SokolClare TwistKieuhoa VoTanya WattSuzanne WoldenPeter ZageRyan SchonfeldLisa HangPublished in: Journal of the National Comprehensive Cancer Network : JNCCN (2024)
Neuroblastoma is the most common extracranial solid tumor diagnosed in children. This inaugural version of the NCCN Guidelines for Neuroblastoma provides recommendations for the diagnosis, risk classification, and treatment of neuroblastoma. The information in these guidelines was developed by the NCCN Neuroblastoma Panel, a multidisciplinary group of representatives with expertise in neuroblastoma, consisting of pediatric oncologists, radiologists, pathologists, surgeons, and radiation oncologists from NCCN Member Institutions. The evidence-based and consensus recommendations contained in the NCCN Guidelines are intended to guide clinicians in selecting the most appropriate treatments for their patients with this clinically heterogeneous disease.